Limbrel Capsules Linked to Potentially Deadly Health Problems

On December 5, 2017, the Federal Drug Administration (FDA) recommended that Limbrel capsules, intended for the treatment of osteoarthritis, be recalled. The FDA advisory concerning Limbrel, which is manufactured by Primus Pharmaceuticals, stated that the product has been connected to incidents of liver injury and other serious health issues. The agency recommended that consumers immediately…

Read More